Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy Phase II (Afya 2 Phase2)
HIV (Human Immunodeficiency Virus)
About this trial
This is an interventional other trial for HIV (Human Immunodeficiency Virus) focused on measuring Antiretroviral Treatment Adherence, Conditional Cash Transfers, Tanzania, People Living With HIV, Behavioral Economics
Eligibility Criteria
Inclusion Criteria:
- Greater than or equal to 18 years of age
- Living with HIV infection
- Initiated on antiretroviral therapy less than or equal to 1 month prior to enrollment in the study
- Have access to a mobile phone (ownership, shared ownership, or access to a trusted person's phone)
- Do not intend to transfer to a different facility for HIV care within the following 12 months.
Exclusion Criteria:
-
Sites / Locations
- Health for a Prosperous Nation (HPON)
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Conditional Cash Transfer
Control
Participants attending intervention clinics will have the opportunity to receive up to 6 consecutive monthly cash transfers of 22,500 TSH (~$10) each, conditional on visit attendance with the HIV care provider. Cash transfers will be given once monthly for up to 6 months, spaced ≥25 days apart (consistent with National Guidelines for monthly or bimonthly visits) and are conditional on visit attendance. This means that the cash transfer is only given when the patient visits the clinic for their routine appointment, regardless of whether the visit is earlier or later than the scheduled appointment.
Participants attending control clinics will receive the standard of care.